
Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 ...
Introduction Liver cancer ranks third globally in terms of cancer-related mortality and is the sixth most common type of cancer,1 with significant geographic heterogeneity.2 The most prevalent type of liver tumor is hepatocellular carcinoma (HCC), accounts …